|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of immune
system related diseases and disorders, c... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders, co... |
|
2023
|
Invention
|
Formulations for anti-c1q antibodies. The present disclosure is generally directed to pharmaceuti... |
|
|
Invention
|
Inhibitors of complement factors and uses thereof.
Disclosed are compounds of formula I and II a... |
|
|
Invention
|
Compositions and methods for treating brain injury.
The present disclosure relates generally to ... |
|
|
Invention
|
Compositions and methods for treating lupus nephritis.
The present disclosure relates generally ... |
|
|
Invention
|
Compositions and methods for treating lupus nephritis. The present disclosure relates generally t... |
|
|
Invention
|
Compositions and methods for treating ocular diseases.
The present disclosure relates generally ... |
|
|
Invention
|
Compositions and methods for treating ocular diseases. The present disclosure relates generally t... |
|
|
Invention
|
Anti-complement factor c1q antibodies and uses thereof.
The present invention provides anti-C1q ... |
|
|
Invention
|
Humanized anti-complement factor c1q antibodies and uses thereof.
The present disclosure is dire... |
|
|
Invention
|
Inhibitors of complement factors and uses thereof. Disclosed are compounds of formula I and II an... |
|
2022
|
Invention
|
Compositions and methods for treating huntington’s disease.
The present disclosure relates gener... |
|
|
Invention
|
Compositions and methods for treating huntington's disease. The present disclosure relates genera... |
|
|
Invention
|
Anti-complement factor c1q antibodies with single binding arms and uses thereof.
The present dis... |
|
|
Invention
|
Anti-complement factor c1q antibodies with single binding arms and uses thereof. The present disc... |
|
|
Invention
|
Compositions and methods for treating muscular dystrophy.
The present disclosure relates general... |
|
|
Invention
|
Compositions and methods for treating muscular dystrophy. The present disclosure relates generall... |
|
2021
|
Invention
|
Compositions and methods for treating blood disorders. The present disclosure relates generally t... |
|
|
Invention
|
Compositions and methods for treating epilepsy.
The present disclosure relates generally to meth... |
|
|
Invention
|
Compositions and methods for treating epilepsy. The present disclosure relates generally to metho... |
|
|
Invention
|
Anti-complement factor c1q antibodies and uses thereof. The present invention provides anti-C1q a... |
|
2020
|
Invention
|
Compositions and methods for treating blood disorders.
The present disclosure relates generally ... |
|
|
Invention
|
Anti-complement factor c1q fab fragments and uses thereof. The present disclosure relates general... |
|
2019
|
Invention
|
Compositions and methods for treating brain injury. The present disclosure relates generally to m... |
|
2017
|
Invention
|
Compositions and methods for treating frontotemporal dementia. The present disclosure relates gen... |
|
|
Invention
|
Anti-complement factor c4/c4b antibodies and uses thereof.
The present disclosure relates genera... |
|
|
Invention
|
Anti-complement factor c4/c4b antibodies and uses thereof. The present disclosure relates general... |
|
|
Invention
|
Compositions and methods for treating spinal muscular atrophy.
The present disclosure relates ge... |
|
|
Invention
|
Compositions and methods for treating spinal muscular atrophy. The present disclosure relates gen... |
|
2015
|
Invention
|
Methods of treatment for guillain-barre syndrome.
This invention relates generally to methods of... |
|
|
Invention
|
Humanized anti-complement factor c1q antibodies. The present disclosure is directed to humanized ... |
|
|
Invention
|
Humanized anti-complement factor c1q antibodies and uses thereof. The present disclosure is direc... |
|
|
Invention
|
Methods for screening for inhibitors of complement serine proteases. The present disclosure relat... |
|
2014
|
Invention
|
Anti-complement factor c1s antibodies and uses thereof.
The present invention relates generally ... |
|
|
Invention
|
Methods of treatment for neuromyelitis optica.
The present disclosure relates generally to metho... |
